TWO SIGMA INVESTMENTS, LP

Position in SEER — Seer, Inc.

CIK 1179392 NEW YORK, NY

Position in SEER

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$817,214

-$42,270 QoQ

Shares Held

492,298

-3.8% QoQ

Ownership

0.889%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 59 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. SEER ranks #216 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$817,214	492,298	-3.8%	Shares	Sole	2026-08-14
2026-03-31	$859,484	511,598	+102.5%	Shares	Sole	2026-05-15
2025-12-31	$462,344	252,647	-13.6%	Shares	Sole	2026-02-17
2025-09-30	$634,304	292,306	+1.7%	Shares	Sole	2025-11-14
2025-06-30	$615,085	287,423	-6.0%	Shares	Sole	2025-08-14
2025-03-31	$516,671	305,723	-34.9%	Shares	Sole	2025-05-15
2024-12-31	$1,084,748	469,588	-2.7%	Shares	Sole	2025-02-14
2024-09-30	$950,560	482,518	+18.4%	Shares	Sole	2024-11-14
2024-06-30	$684,677	407,546	-4.4%	Shares	Sole	2024-08-14
2024-03-31	$810,211	426,427	+40.4%	Shares	Sole	2024-05-15
2023-12-31	$589,253	303,739	+1124.8%	Shares	Sole	2024-02-14
2023-06-30	$105,896	24,800	+60.0%	Shares	Sole	2023-08-14
2023-03-31	$59,830	15,500	-34.9%	Shares	Sole	2023-05-15
2021-12-31	$543,379	23,822	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.